Alvotech
Alvotech
- Market cap
- $1.22B
Your view on ALVOW
Overview
What the company does, where it operates, and who runs it.
About Alvotech
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Lisa Graver
- Headquarters
- 9, Rue de Bitbourg, Luxembourg, LU, LU
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Lisa Graver
- Headquarters
- 9, Rue de Bitbourg, Luxembourg, LU, LU
Alvotech Holdings SA is an Icelandic enterprise that, operating via its subsidiary companies, undertakes the development and fabrication of biosimilar pharmaceuticals destined for international consumption.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Alvotech. Starting points for Alvotech: EPS -$0.76, beta 0.19 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Alvotech. Trailing twelve-month EPS for Alvotech stands at -$0.76. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | $0.17 | −$0.01 | −$0.09 | $0.25 |
| Lowest estimate | $0.17 | −$0.01 | −$0.09 | $0.23 |
| Highest estimate | $0.17 | −$0.01 | −$0.08 | $0.27 |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | $0.011 | −$0.091 | $0.101 | — |
| Growth vs a year ago | — | — | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | $293.10M | $171.20M | $590.82M | $737.01M |
| Lowest estimate | $293.10M | $171.20M | $581.45M | $669.83M |
| Highest estimate | $293.10M | $171.20M | $597.41M | $832.53M |
| Number of analysts | 1 | 1 | 6 | 6 |
| A year ago | $166.36M | $105.86M | $586.32M | — |
| Growth vs a year ago | +76.2% | +61.7% | +0.8% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Alvotech. Alvotech has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| AMGNAmgen Inc. | Healthcare | Drug Manufacturers - General | $235.6B | ||
| AMPHAmphastar Pharmaceuticals, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | $1.2B | ||
| AMRXAmneal Pharmaceuticals, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | $7.4B | ||
| BIIBBiogen Inc. | Healthcare | Drug Manufacturers - General | $36.9B | ||
| COLLCollegium Pharmaceutical, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | $768.2M | ||
| ETONEton Pharmaceuticals, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | $1.8B | ||
| HROWHarrow Health, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | $1.1B | ||
| OGNOrganon & Co. | Healthcare | Drug Manufacturers - General | $3.6B | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| WEED.TOCanopy Growth Corporation | Healthcare | TSX | $283.3M | ||
| WIBFFWest Island Brands Inc. | Healthcare | OTC | $60,061 | ||
| WLDFFWildflower Brands Inc. | Healthcare | OTC | $1,393 | ||
| WOWUWOWI, Inc. | Healthcare | OTC | $6,761 | ||
| XBRAFXebra Brands Ltd. | Healthcare | OTC | $106,760 | ||
| XLY.TOAuxly Cannabis Group Inc. | Healthcare | TSX | $358.2M | ||
| XTXXFAdastra Holdings Ltd. | Healthcare | OTC | $55,971 | ||
| YCBDcbdMD, Inc. | Healthcare | AMEX | $4.0M | ||
| YOURFYourWay Cannabis Brands Inc. | Healthcare | OTC | $2,879 | ||
| ZTSZoetis Inc. | Healthcare | NYSE | $32.1B | ||
| ZYBTZhengye Biotechnology Holding Limited | Healthcare | NASDAQ | $70.1M | ||
| TSND.TOTerrAscend Corp. | Healthcare | TSX | $160.1M | ||
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Alvotech, and how their positions are changing. At a $1.22B market value, institutional positions materially move Alvotech's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Alvotech. Coverage tracks Alvotech within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Alvotech.